The European Tribune is a forum for thoughtful dialogue of European and international issues. You are invited to post comments and your own articles.
Please REGISTER to post.
If I interpret the language correctly (I am a native English speaker, but DoH seems to write in something else) the most obvious potential for devilry is in the tariff-setting. If it's slightly wrong, some activities will be more profitable than others. In a PbR system, who's going to want to do the less profitable types of clinical work?
So if you have the 'wrong' type of illness, tough luck!
No idea if there's a mechanism to correct for this. NuLab's managerial abilities in other fields suggests not.
by Frank Schnittger - Sep 1 6 comments
by Frank Schnittger - Sep 3 12 comments
by Oui - Sep 6 2 comments
by gmoke - Aug 25 1 comment
by Frank Schnittger - Aug 21 1 comment
by Frank Schnittger - Aug 22 56 comments
by Oui - Aug 18 8 comments
by Frank Schnittger - Aug 12 25 comments
by Oui - Sep 8
by Oui - Sep 7
by Oui - Sep 62 comments
by Oui - Sep 52 comments
by gmoke - Sep 5
by Oui - Sep 41 comment
by Oui - Sep 47 comments
by Frank Schnittger - Sep 312 comments
by Oui - Sep 211 comments
by Frank Schnittger - Sep 16 comments
by Oui - Sep 114 comments
by Oui - Sep 173 comments
by Oui - Sep 11 comment
by gmoke - Aug 29
by Oui - Aug 2818 comments
by Oui - Aug 271 comment
by Oui - Aug 262 comments
by Oui - Aug 2626 comments